NEOGENOMICS INC|4Nov 25, 6:04 PM ET

CARDOZA GEORGE 4

4 · NEOGENOMICS INC · Filed Nov 25, 2020

Form 4

Period: 2020-11-24

Chief Financial Officer

Transactions

Sale
Common Stock
2020-11-25$45.48/sh−77,074$3,505,326→ 370,902 total
Sale
Common Stock
2020-11-24$45.19/sh−52,926$2,391,726→ 370,902 total
Exercise/Conversion
Common Stock
2020-11-25$7.52/sh+77,074$579,596→ 447,976 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-11-24−72,926→ 127,074 total
Exercise: $7.52Exp: 2022-04-28→ Common Stock (72,926 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-11-25−77,074→ 50,000 total
Exercise: $7.52Exp: 2022-04-28→ Common Stock (77,074 underlying)
Exercise/Conversion
Common Stock
2020-11-24$7.52/sh+72,926$548,404→ 423,828 total

Holdings

Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (51,459 underlying)
51,459
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (192,500 underlying)
192,500
Common Stock
(indirect: By Trust)
20,000
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (48,768 underlying)
48,768

Footnotes (4)

[F1]On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
[F2]On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F3]On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F4]On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file